Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • MVP eyes increased global distribution of Penthrox green whistle after raising $20m
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • MVP eyes increased global distribution of Penthrox green whistle after raising $20m
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • MVP eyes increased global distribution of Penthrox green whistle after raising $20m
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • MVP eyes increased global distribution of Penthrox green whistle after raising $20m
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • MVP eyes increased global distribution of Penthrox green whistle after raising $20m
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • Medical Developments eyes US commercialisation for Penthrox as it scales back in France
    Medical Developments eyes US commercialisation for Penthrox as it scales back in France
    • News

  • MVP discontinues clinical trials in China for Green Whistle, focuses on growth in the US
    MVP discontinues clinical trials in China for Green Whistle, focuses on growth in the US
    • News

  • MVP eyes increased global distribution of Penthrox green whistle after raising $20m
    MVP eyes increased global distribution of Penthrox green whistle after raising $20m
    • News

  • Regeneus begins to etch pathway to drug commercialisation, exuding confidence in their tech
    Regeneus begins to etch pathway to drug commercialisation, exuding confidence in their tech
    • News

  • Wellfully set to jump into $9 billion market with FDA registration for their knee pain patch
    Wellfully set to jump into $9 billion market with FDA registration for their knee pain patch
    • News

  • Pure Foods Tasmania eyes Aussie meals to Asia with potato farm acquisition
    • News

    Pure Foods Tasmania eyes Aussie meals to Asia with potato farm acquisition

    With changing trends in the way we prepare meals where convenience is in demand, Pure Foods Tasmania (ASX: PFT) is set to significantly expand its meal solutions range with the acquisition of Daly Potato Company and its potato-based meals, farm and food products. The acquisition will increase the production and export capabilities of Pure Foods

    Read More
    Public
  • Aussies flock to newly ASX-listed BNPL provider Laybuy on opening day
    • News

    Aussies flock to newly ASX-listed BNPL provider Laybuy on opening day

    The buy-now-pay-later train is showing no signs of slowing down with Australian investors keen to jump aboard new BNPL investment opportunities as evidenced by the opening day of trade for Laybuy Group (ASX: LBY) as an ASX-listed company. Founded in 2017 by Gary Rohloff and his family in New Zealand, Laybuy Group has emerged as

    Read More
    Public
  • Cannabis toothpaste is a thing, and Zelira Therapeutics are commercialising it
    • News

    Cannabis toothpaste is a thing, and Zelira Therapeutics are commercialising it

    Furthering their expertise in the field of cannabinoid-based therapeutics, Zelira Therapeutics (ASX: ZLD) is set to tap into the oral care market with the launch of hemp derived toothpaste in the United States.  The toothpaste formulation was created by Sprinjene CEO and Founder, Dr Sayed Abrahim who developed the oral care product which is gluten-free,

    Read More
    Public
  • Digital Wines to offer BNPL for wine purchases up to $250,000
    • News

    Digital Wines to offer BNPL for wine purchases up to $250,000

    Joining in on the market frenzy for all things related to buy-now-pay-later, Digital Wine Ventures (ASX: DW8) has launched its own offering of the phenomenon in the form of Credit-as-a-Service (CaaS) where customers will be able to buy up to $250,000 of wine from their platform, and pay later.  Intended to operate like BNPL market

    Read More
    Public
  • SenSen to bring AI to Australia for driverless car testing
    • News

    SenSen to bring AI to Australia for driverless car testing

    Tech and artificial intelligence company SenSen Networks (ASX: SNS) is poised to accelerate Australia’s transition towards driverless vehicles having commenced a collaboration with ACE Electric Vehicles Group to push Australia’s manufacturing capabilities.  Specialising in smart city technology using multi-camera and multi-sensor data, SenSen already has significant AI on traffic data through their current capabilities which

    Read More
    Public
  • Former ASX darling GetSwift to delist, heads to North America
    • News

    Former ASX darling GetSwift to delist, heads to North America

    Troubled tech company GetSwift (ASX: GSW) is set to bring an end to their time on the ASX after several controversial years, with plans to re-domicile to Canada at a time when an impending class action against the Company is set for trial. The former market darling which listed on the ASX in December 2016

    Read More
    Public
  • New Novatti app brings top end billing automation to small business
    • News

    New Novatti app brings top end billing automation to small business

    Small business operators will soon have access to an end-to-end billing, payments and sales management system with Novatti Group (ASX: NOV) having gained approval from Salesforce for the inclusion of the Emersion payments app on the Salesforce AppExchange marketplace.  The Emersion app, launched by wholly-owned subsidiary Emersion Systems, integrates many of the features offered to

    Read More
    Public
  • BrianChip collaborates to optimise AI chip for aerospace applications
    • News

    BrianChip collaborates to optimise AI chip for aerospace applications

    As the United States accelerates its aerospace program, artificial intelligence is likely to play a major role in future discoveries where deep tech company BrainChip (ASX: BRN) has entered into a collaboration with VORAGO Technologies to optimise processor chips for extreme conditions. The collaboration is intended to support a Phase I NASA Program from BrainChip’s

    Read More
    Public
  • Founders First to launch seltzer range as drinkers seek healthy alcopops
    • News

    Founders First to launch seltzer range as drinkers seek healthy alcopops

    As Australians seek healthier alternatives to traditional pleasure foods, the alcohol sector is following the same trend, prompting beer and liquor company Founders First (ASX: FFL) to secure equity in Torquay Beverage Company in preparation for the launch of a new seltzer range. Produced by TBC, NoSH Boozy Seltzer will be sold in more than

    Read More
    Public
  • Gefen Technologies secures A$4m in oversubscribed pre-IPO capital raising
    • News

    Gefen Technologies secures A$4m in oversubscribed pre-IPO capital raising

    Digital distribution platform provider Gefen Technologies today announced that it has closed a pre-Initial Public Offering (IPO) convertible note offer, successfully raising approximately $4m ahead of its anticipated listing on the Australian Securities Exchange (ASX). The round was heavily oversubscribed, raising double the planned A$2m after significant scalebacks. Sophisticated and institutional investors supported the pre-IPO

    Read More
    Public
  • «
  • ‹
  • 276
  • 277
  • 278
  • 279
  • 280
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.